Jonsson Comprehensive Cancer Center: all 398 studies
Page 2 of 4. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.
- Psychoeducation for Uveal MelanomaActive, not recruitingNCT06075589Not applicable
- Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for GuidanceTerminatedNCT06047509Not applicable
- CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNCT05950113Phase 1
- Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic CancerTerminatedNCT05841706Early Phase 1
- Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid LeukemiaWithdrawnNCT05720988Phase 1
- Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)CompletedNCT05523700Not applicable
- 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR StudyActive, not recruitingNCT05496959Phase 2
- Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutantWithdrawnNCT05457959Phase 1
- Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerActive, not recruitingNCT05319873Phase 1/2
- Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive BiopsyActive, not recruitingNCT05160597Early Phase 1
- Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation TherapyActive, not recruitingNCT05115760Not applicable
- Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent GliomaActive, not recruitingNCT05045027Early Phase 1
- A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer SurvivorsWithdrawnNCT05000359Early Phase 1
- 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyTerminatedNCT04928820Phase 2
- Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical ProstatectomyActive, not recruitingNCT04915508Phase 2
- ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent GlioblastomaWithdrawnNCT04854044Phase 1
- BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver CancerTerminatedNCT04777708Early Phase 1
- Pembrolizumab for the Treatment of Cervical Intraepithelial NeoplasiaActive, not recruitingNCT04712851Phase 2
- Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerTerminatedNCT04705025Not applicable
- Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA TrialActive, not recruitingNCT04624256Not applicable
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell CancerWithdrawnNCT04603365Phase 2
- Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerTerminatedNCT04473781Phase 1
- Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRITerminatedNCT04460495Not applicable
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersActive, not recruitingNCT04459273Phase 1
- 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With SarcomaActive, not recruitingNCT04457258Early Phase 1
- Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerTerminatedNCT04457245Phase 3
- Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology ValidationActive, not recruitingNCT04457232Phase 1
- Cryoablation for the Promotion of Local Tumor Infiltration in Patients With MesotheliomaWithdrawnNCT04429204Not applicable
- Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaActive, not recruitingNCT04420975Phase 1
- Role of Children in Transmission of COVID-19 to Immunocompromised PatientsTerminatedNCT04407546
- Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate CancerWithdrawnNCT04399824Not applicable
- Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological MalignanciesActive, not recruitingNCT04395079Phase 2
- CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE StudyActive, not recruitingNCT04384770
- Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype MelanomaTerminatedNCT04375527Phase 2
- Expanded Access Protocol of 68Ga-PSMA-11 for PET ImagingApproved for marketingNCT04348682
- Focal Laser Ablation of Prostate CancerCompletedNCT04305925Early Phase 1
- Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical ProstatectomyActive, not recruitingNCT04299620Not applicable
- Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaActive, not recruitingNCT04299113Phase 1
- Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsCompletedNCT04290897Phase 2
- Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung CancerActive, not recruitingNCT04285671Phase 1/2
- Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate CancerCompletedNCT04282824Early Phase 1
- Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host DiseaseWithdrawnNCT04280471Phase 1
- Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerTerminatedNCT04279561Phase 1
- Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell LymphomaTerminatedNCT04205838Phase 2
- Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent GlioblastomaCompletedNCT04201873Phase 1
- Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedTerminatedNCT04185311Phase 1
- Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell CarcinomaTerminatedNCT04106362Phase 2
- OsteoCrete in Filling Bone Voids in Participants With Bone Voids or DefectsCompletedNCT04069923Not applicable
- Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain MetastasesWithdrawnNCT04069910Not applicable
- 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerCompletedNCT04050215Phase 2
- Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaActive, not recruitingNCT04007029Phase 1
- SPECT/CT for the Characterization of Renal MassesActive, not recruitingNCT03996850
- Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic CancerCompletedNCT03970252Early Phase 1
- Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase InhibitorsCompletedNCT03953157Not applicable
- CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid LeukemiaTerminatedNCT03904251Phase 1
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerActive, not recruitingNCT03902951Phase 2
- Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck CancerCompletedNCT03892720Not applicable
- Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyActive, not recruitingNCT03830918Phase 1/2
- CPX-351 Plus Enasidenib for Relapsed AMLActive, not recruitingNCT03825796Phase 2
- Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck CancerWithdrawnNCT03745690Phase 1/2
- Pembrolizumab in Treating Participants With Recurrent Ovarian CancerActive, not recruitingNCT03732950Phase 2
- 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent GlioblastomaCompletedNCT03732352Phase 2
- Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung CancerActive, not recruitingNCT03672773Phase 2
- Nivolumab and Relatlimab in Treating Participants With Advanced ChordomaCompletedNCT03623854Phase 2
- Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell CanerTerminatedNCT03618134Phase 1/2
- Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder CancerActive, not recruitingNCT03601455Phase 2
- Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand TherapyWithdrawnNCT03596710Not applicable
- Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical ProstatectomyActive, not recruitingNCT03582774Phase 3
- CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung CancerActive, not recruitingNCT03546361Phase 1
- Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone SurgeryActive, not recruitingNCT03541850Phase 2
- Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryCompletedNCT03515577Phase 2
- TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple MyelomaWithdrawnNCT03506802Phase 1
- Hemi-Gland Cryoablation for Prostate Cancer at UCLACompletedNCT03503643
- Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV MelanomaTerminatedNCT03425461Phase 1
- SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast CancerCompletedNCT03411070Early Phase 1
- PET Imaging of the Immune System Using Analog ProbesCompletedNCT03409419
- Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With TrametinibNo longer availableNCT03386071
- 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before SurgeryCompletedNCT03368547Not applicable
- Kindness Interventions in Enhancing Well-Being in Breast Cancer SurvivorsCompletedNCT03319342Not applicable
- Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced CancerTerminatedNCT03240861Phase 1
- Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body RadiotherapyTerminatedNCT03148327Phase 1/2
- Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTerminatedNCT03128619Phase 1
- Single Patient Expanded Access to Ganitumab for Metastatic Ewing SarcomaNo longer availableNCT03029481
- Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)Status unknownNCT03025139Not applicable
- Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent GlioblastomaWithdrawnNCT03014804Phase 2
- Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial TherapyCompletedNCT02940262Phase 3
- Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic LymphomaTerminatedNCT02928510
- Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory DiseasesCompletedNCT02925351Early Phase 1
- Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With GlioblastomaWithdrawnNCT02919332
- FDG PET/CT in Monitoring Very Early Therapy Response in Patients With GlioblastomaCompletedNCT02902757Not applicable
- 18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After InterventionsTerminatedNCT02888301
- Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate CancerActive, not recruitingNCT02881242Phase 2
- Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02880020Phase 2
- Project Connect Online: An Internet-based Intervention for Women With Breast CancerCompletedNCT02866994Not applicable
- Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic CancerWithdrawnNCT02851381Not applicable
- C11 Sodium Acetate PET/CT Imaging of PCaNo longer availableNCT02826395
- Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With MenActive, not recruitingNCT02816879Not applicable
- Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1CompletedNCT02775292Phase 1
- Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)WithdrawnNCT02756130Phase 1/2
← Jonsson Comprehensive Cancer Center overview and focus areas